Published in Women's Health Law Weekly, June 5th, 2005
"hUCB mononuclear cells containing 0.11% to 1.1% CD34+ cells were injected in the tail vein of non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice that had myocardial infarction (MI+) or had not (MI-) previously undergone ligation of the left anterior coronary artery (LAD). Homing to bone marrow and solid organs was determined by polymerase chain reaction (PCR)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.